Anavex Life Sciences Corp (AVXL)

[stealthways]

Gilead paid $11 Billion for its Hep drug in phase 2.... IMO (and just talking about USA now) it is fast movers, below radar but cash rich companies, like Gilead used to be, that avxl has the best chances of a partnership or deal from, here in America... I also think the avxl platform is worth 2 or 3 times what Gilead bought (comparing avxl now to what Gilead bought back at their initial purchase date) ... they jumped the line up and grabbed what they knew was a good deal while all the industry players did thumb fiddling and played typical games....
Floating an additional thought here, was thinking that as far as Industry players here now, if they think AVXL is asking too much, it actually might make sense for them to try and drive avxl into doing PUBLIC (i.e. retail) financing at undervalued prices (by the campaign of bashing, shorting etc, ) since they know/think that they can own those retail shares ultimately anyways (and they think cheaper than what avxl is asking) .... especially if they can create a culture of trading amongst the shareholders.....and also important knowing they have better **access** and **early** knowledge to information..... In essence they might look at retails shares as a temporary holding pen financed by retail , but for them, at no cost...